NUCLEAR MEDICINE COMMUNICATIONS, vol.33, no.3, pp.268-274, 2012 (Journal Indexed in SCI)
Article / Article
Title of Journal :
NUCLEAR MEDICINE COMMUNICATIONS
iodine-131, radioiodine ablation, thyroid cancer, LOW-DOSE RADIOIODINE, WHOLE-BODY SCAN, SERUM THYROGLOBULIN, RADIOACTIVE IODINE, FOLLOW-UP, THERAPY, CARCINOMA, PAPILLARY, ULTRASONOGRAPHY, MANAGEMENT
Introduction The initial treatment of differentiated thyroid cancer is thyroidectomy, followed by remnant ablation with iodine-131 (I-131) in some patients. However, controversy exists concerning the appropriate radioiodine dose. The aim of the study is to compare the success rate of low and high activities of I-131 for postoperative remnant ablation.